Search Results
Abstracts
HPV DNA Screening for Cervical Cancer in a Resource-limited setting –Experiences From a Cohort of Women Living With HIV in Zimbabwe.
A. Mandiriri
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Adolescent girl-led participatory action research: early lessons from a sport-based cluster randomised trial in Cape Town, South Africa
C. Coakley
Reviews in Antiviral Therapy & Infectious Diseases 8, 2020
Presented at:
International Workshop on HIV & Adolescence 2020
Slidesets
Eliminating Viral Hepatitis - Perspectives From (Some Members of) the South African Harm Reduction Community - Andrew Scheibe
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Slidesets
How Things Will Change After COVID-19 From a Healthcare Provider Perspective - Linda-Gail Bekker, MBCHB, DTMH, DCH, FCP(SA), PhD
Presented at:
International Workshop on Innovations in Delivery of HIV Care 2021
Abstracts
Reasons for new paediatric HIV infections: findings from a cohort of HIV infected children screened at Harare Family Care Clinical Research Site.
Presented at:
International Workshop on HIV & Pediatrics 2019
Abstracts
“Bring back mother-baby pair” campaign Initiative to improve retention in care: Experience from the Uganda program for Prevention of Mother to child transmission of HIV
J. Ssendiwala
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Videos
PrEP: Updates on Programs from Across the Region - Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD
Presented at:
2nd African Workshop on Women & HIV 2025
Videos
Case-Based Discussion of Oral Antivirals for COVID-19: Learning from Experience – Part 2 | Fiona Marra, MPharm, MSc
Presented at:
Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022
Videos
Case-Based Discussion of Oral Antivirals for COVID-19: Learning from Experience - Part 1 | Catia Marzolini, PharmD, PhD
Presented at:
Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022
E-Posters
Outcomes of HIV pre-exposure prophylaxis (PrEP) program in Georgia for the reporting period from October 2017 to June 2021
E. Karkashadze
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021